HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

[Anticonvulsant and neuroprotective effects of cyclopentyladenosine on the model of convulsive status in rats].

Abstract
The neuroprotective and anticonvulsant effects of cyclopentyladenosine (CPA) have been studied on a new experimental model of the convulsive status in rats aged 3-4 months and 10 days. The convulsive status was modeled by intracerebroventricular injection of ferakril (water-soluble polymer of polyacrylic acid) solution. It is established that prophylactic administration of CPA results in a relatively lower degree of neurological deficit, both in the acute phase and on the next day, compared to the untreated control. Considering that adenosine receptor agonists are analogs of the natural metabolites that have minimal side effects and expressed neuroprotective properties, the use of agents of this group is perspective for both prevention and treatment of seizure conditions in neurology and neurosurgery.
AuthorsG Z Sufianova, A A Sufianov, A G Shapkin
JournalEksperimental'naia i klinicheskaia farmakologiia (Eksp Klin Farmakol) Vol. 76 Issue 11 Pg. 13-8 ( 2013) ISSN: 0869-2092 [Print] Russia (Federation)
PMID24555227 (Publication Type: English Abstract, Journal Article)
Chemical References
  • Acrylic Resins
  • Anticonvulsants
  • Neuroprotective Agents
  • Feracryl
  • Adenosine
Topics
  • Acrylic Resins (toxicity)
  • Adenosine (analogs & derivatives, pharmacology)
  • Animals
  • Anticonvulsants (pharmacology)
  • Disease Models, Animal
  • Neuroprotective Agents (pharmacokinetics)
  • Rats
  • Seizures (chemically induced, drug therapy, pathology, physiopathology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: